Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial von Menter, Alan, MD, Tyring, Stephen K., MD, PhD, MBA, Gordon, Kenneth, MD, Kimball, Alexa B., MD, MPH, Leonardi, Craig L., MD, Langley, Richard G., MD, Strober, Bruce E., MD, PhD, Kaul, Martin, MD, Gu, Yihua, MS, Okun, Martin, MD, PhD, Papp, Kim, MD

Volltext

Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa von Kimball, Alexa B, Okun, Martin M, Williams, David A, Gottlieb, Alice B, Papp, Kim A, Zouboulis, Christos C, Armstrong, April W, Kerdel, Francisco, Gold, Michael H, Forman, Seth B, Korman, Neil J, Giamarellos-Bourboulis, Evangelos J, Crowley, Jeffrey J, Lynde, Charles, Reguiai, Ziad, Prens, Errol-Prospero, Alwawi, Eihab, Mostafa, Nael M, Pinsky, Brett, Sundaram, Murali, Gu, Yihua, Carlson, Dawn M, Jemec, Gregor B.E

Volltext

Long-term efficacy and safety of adalimumab in patients with moderate to severe psoriasis treated continuously over 3 years: Results from an open-label extension study for patients... von Gordon, Kenneth, MD, Papp, Kim, MD, PhD, Poulin, Yves, MD, Gu, Yihua, MS, Rozzo, Stephen, PhD, Sasso, Eric H., MD

Volltext

Causal associations between circulating protein ratios and drug resistance in papillary thyroid cancer: a Mendelian randomization study von Deng, Jiaqin, Yu, Ming, Gu, Yihua, Lai, Yeqian, Qiu, Lihong

Volltext

Unraveling the role of gut microbiota and immune cells in thyroid cancer and tumor drug resistance von Deng, Jiaqin, Gu, Yihua, Yu, Ming, Lai, Yeqian, Qiu, Lihong

Volltext

A Phase III, Randomized, Controlled Trial of the Fully Human IL-12/23 mAb Briakinumab in Moderate-to-Severe Psoriasis von Gordon, Kenneth B., Langley, Richard G., Gottlieb, Alice B., Papp, Kim A., Krueger, Gerald G., Strober, Bruce E., Williams, David A., Gu, Yihua, Valdes, Joaquin M.

Volltext

Efficacy and safety of adalimumab across subgroups of patients with moderate to severe psoriasis von Menter, Alan, MD, Gordon, Kenneth B., MD, Leonardi, Craig L., MD, Gu, Yihua, MS, Goldblum, Orin M., MD

Volltext

An automation-based adaptive seamless design for dose selection and confirmation with improved power and efficiency von Cui, Lu, Zhan, Tianyu, Zhang, Lanju, Geng, Ziqian, Gu, Yihua, Chan, Ivan SF

Volltext

Switching to adalimumab for psoriasis patients with a suboptimal response to etanercept, methotrexate, or phototherapy: Efficacy and safety results from an open-label study von Strober, Bruce E., MD, PhD, Poulin, Yves, MD, Kerdel, Francisco A., MD, Langley, Richard G., MD, Gu, Yihua, MS, Gupta, Shiraz R., PharmD, MPH, Okun, Martin M., MD, PhD, Papp, Kim A., MD, PhD

Volltext

Adalimumab treatment optimization for psoriasis: Results of a long-term phase 2/3 Japanese study von Asahina, Akihiko, Ohtsuki, Mamitaro, Etoh, Takafumi, Gu, Yihua, Okun, Martin M., Teixeira, Henrique D., Yamaguchi, Yuji, Nakagawa, Hidemi

Volltext

A Human Lectin Microarray for Sperm Surface Glycosylation Analysis von Sun, Yangyang, Cheng, Li, Gu, Yihua, Xin, Aijie, Wu, Bin, Zhou, Shumin, Guo, Shujuan, Liu, Yin, Diao, Hua, Shi, Huijuan, Wang, Guangyu, Tao, Sheng-ce

Volltext

The Long-Term Safety of Adalimumab Treatment in Moderate to Severe Psoriasis: A Comprehensive Analysis of All Adalimumab Exposure in All Clinical Trials von Leonardi, Craig, Papp, Kim, Strober, Bruce, Reich, Kristian, Asahina, Akihiko, Gu, Yihua, Beason, Joseph, Rozzo, Stephen, Tyring, Stephen

Volltext

Phosphorylation of Dynamin-Related Protein 1 (DRP1) Regulates Mitochondrial Dynamics and Skeletal Muscle Wasting in Cancer Cachexia von Mao, Xiangyu, Gu, Yihua, Sui, Xiangyu, Shen, Lei, Han, Jun, Wang, Haiyu, Xi, Qiulei, Zhuang, Qiulin, Meng, Qingyang, Wu, Guohao

Volltext

Effects of low lead exposure on sperm quality and sperm DNA methylation in adult men von Zhang, Tiancheng, Ru, Yan Fei, Wu, Bin, Dong, Haiyan, Chen, Liang, Zheng, Jufen, Li, Jianhui, Wang, Xin, Wang, Zhikai, Wang, Xuemei, Shen, Xiaorong, Wu, Jun, Qian, Jun, Miao, Maohua, Gu, Yihua, Shi, Huijuan

Volltext

Trehalose maintains vitality of mouse epididymal epithelial cells and mediates gene transfer von Qu, Bin, Gu, Yihua, Shen, Jian, Qin, Jinzhou, Bao, Jianqiang, Hu, Yuan, Zeng, Wenxian, Dong, Wuzi

Volltext

Risankizumab compared with adalimumab in patients with moderate-to-severe plaque psoriasis (IMMvent): a randomised, double-blind, active-comparator-controlled phase 3 trial von Reich, Kristian, Gooderham, Melinda, Thaçi, Diamant, Crowley, Jeffrey J, Ryan, Caitriona, Krueger, James G, Tsai, Tsen-Fang, Flack, Mary, Gu, Yihua, Williams, David A, Thompson, Elizabeth H Z, Paul, Carle

Volltext

Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-... von Gordon, Kenneth B, Strober, Bruce, Lebwohl, Mark, Augustin, Matthias, Blauvelt, Andrew, Poulin, Yves, Papp, Kim A, Sofen, Howard, Puig, Lluís, Foley, Peter, Ohtsuki, Mamitaro, Flack, Mary, Geng, Ziqian, Gu, Yihua, Valdes, Joaquin M, Thompson, Elizabeth H Z, Bachelez, Hervé

Volltext

Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind,... von Guttman-Yassky, Emma, Teixeira, Henrique D, Simpson, Eric L, Papp, Kim A, Pangan, Aileen L, Blauvelt, Andrew, Thaçi, Diamant, Chu, Chia-Yu, Hong, H Chih-ho, Katoh, Norito, Paller, Amy S, Calimlim, Brian, Gu, Yihua, Hu, Xiaofei, Liu, Meng, Yang, Yang, Liu, John, Tenorio, Allan R, Chu, Alvina D, Irvine, Alan D

Volltext

Upadacitinib in adults with moderate to severe atopic dermatitis: 16-week results from a randomized, placebo-controlled trial von Guttman-Yassky, Emma, Thaçi, Diamant, Pangan, Aileen L., Hong, H. Chih-ho, Papp, Kim A., Reich, Kristian, Beck, Lisa A., Mohamed, Mohamed-Eslam F., Othman, Ahmed A., Anderson, Jaclyn K., Gu, Yihua, Teixeira, Henrique D., Silverberg, Jonathan I.

Volltext

Parametric studies on different gas turbine cycles for a high temperature gas-cooled reactor von Wang, Jie, Gu, Yihua

Volltext